Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single Arm Phase II Study to Investigate the Use of Lenalidomide in the Treatment of Patients With Early Stage CLL Associated With Poor Prognostic Factors

NCT01127542 is registered in ClinicalTrials.gov with The Christie NHS Foundation Trust as lead sponsor.

NCT NCT01127542
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01127542 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single Arm Phase II Study to Investigate the Use of Lenalidomide in the Treatment of Patients With Early Stage CLL Associated With Poor Prognostic Factors
Lead sponsor
The Christie NHS Foundation Trust
Phase
Phase 2
Overall status
Terminated
Start date
May 31, 2010
Completion date
December 31, 2011
Enrollment
1 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

chronic lymphocytic leukaemia